|
Index of reports
> Cases resulting in a serious event (175)
> Cases with Blood Creatinine Increased (15)
Below is the selection of adverse event reports related to Altace (Ramipril) that includes cases resulting in a serious event where reactions include blood creatinine increased.
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from United States on 2007-07-30
Patient:
Adverse reactions / side effects: Syncope, Atrial Fibrillation, Blood Potassium Increased, Blood Creatinine Increased
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Altace
Dosage: 10 mg, qd
Administration route: Oral
Indication: Cardiac Failure
Start date: 2006-12-15
End date: 2007-06-20
Atacand
Dosage: 4 mg, qd
Indication: Cardiac Failure
Start date: 2007-04-18
End date: 2007-05-02
Atacand
Dosage: 8 mg, qd
Administration route: Oral
Start date: 2007-05-03
End date: 2007-06-20
Spironolactone
Dosage: 50 mg, qd
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-01-18
End date: 2007-06-20
Spironolactone
Dosage: 12.5 mg, qd
Administration route: Oral
Start date: 2007-06-21
Other drugs received by patient: Behepan; Zolpidem Tartrate; Imodium / 00384302 /
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from France on 2007-07-26
Patient:
Adverse reactions / side effects: LOW Cardiac Output Syndrome, Vomiting, Dyspnoea, Hyperkalaemia, Drug Interaction, Haemodialysis, Cardiac Failure, Renal Tubular Necrosis, Hypoperfusion, Blood Creatinine Increased, Renal Failure Acute, Anuria
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Administration route: Oral
End date: 2007-05-08
Lasilix / 00032601 /
Administration route: Oral
End date: 2007-05-08
Cordarone / 00133102 /
Dosage: 200 mg, unk
Administration route: Oral
Aldactone
Administration route: Oral
End date: 2007-05-08
Celebrex
Administration route: Oral
Indication: Pain in Extremity
Other drugs received by patient: Previscan / 00789001 /
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from France on 2007-07-16
Patient:
Adverse reactions / side effects: Hyperkalaemia, Bundle Branch Block Right, Bundle Branch Block Left, Fall, Sinus Bradycardia, Grand MAL Convulsion, Lung Disorder, Malaise, Protein Total Increased, Pulmonary Oedema, Blood Creatinine Increased, Sinoatrial Block, Renal Failure Acute, Anuria
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Altace
Dosage: 2.5 mg, qd
Administration route: Oral
End date: 2007-05-09
Cardensiel
Dosage: 2.5 mg, qd
Administration route: Oral
End date: 2007-05-09
Pravidual
Dosage: 40 mg, qd
Administration route: Oral
End date: 2007-05-09
Other drugs received by patient: Previscan / 00789001 /; Metformin HCL; Lasilix / 00032601 /
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from France on 2007-06-27
Patient:
Adverse reactions / side effects: Weight Decreased, Blood Urea Increased, Vomiting, Nausea, Abdominal Pain Upper, Anorexia, Blood Creatinine Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Essential Hypertension
End date: 2007-03-28
Aldactone
Dosage: 75 mg, qd
Administration route: Oral
Indication: Essential Hypertension
End date: 2007-03-28
Other drugs received by patient: Kardegic / 00002703 /; Lasilix / 00032601 /
Adverse event in receiving Altace (Ramipril)
Reported by a physician from Madagascar on 2007-06-18
Patient:
Adverse reactions / side effects: Acute Pulmonary Oedema, Immunoglobulins Increased, Hepatic Failure, Toxic Epidermal Necrolysis, Transaminases Increased, Renal Failure, Cardiac Failure, Blood Creatinine Increased
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Altace
Dosage: 1 tablet, qd
Indication: Cardiac Failure
Hydrochlorothiazide
Dosage: 1 tablet, qd
Indication: Cardiac Failure
Other drugs received by patient: Amaryl; Fenofibrate
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from France on 2007-06-04
Patient:
Adverse reactions / side effects: Blood Urea Increased, Hyperkalaemia, Drug Interaction, Dehydration, Anorexia, Gastroenteritis, Blood Creatinine Increased, Asthenia, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 1u, qd
Administration route: Oral
Tareg
Dosage: 80 mg, qd
Administration route: Oral
Other drugs received by patient: Rivotril; Mixtard / 00634701 /; Buflomedil; Plavix
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from Sweden on 2007-05-30
Patient:
Adverse reactions / side effects: Hyperkalaemia, Unevaluable Event, Blood Creatinine Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace (Ramipril)
Other drugs received by patient: Levaxin; Behepan; Tenormin; Furosemide; Trombyl; Acetylcysteine
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from United States on 2007-05-24
Patient:
Adverse reactions / side effects: Renal Impairment, Anaemia, Blood Creatinine Increased, Lymphocele, Renal Artery Stenosis, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: unk, qd
Administration route: Oral
Unknown Drug RAD 666rad
Dosage: .7 mg, qd
Administration route: Oral
Indication: Renal Transplant
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from United States on 2007-05-21
Patient:
Adverse reactions / side effects: Vascular Calcification, Hyperkalaemia, Hyponatraemia, Blood Creatinine Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 5 mg, qd
Administration route: Oral
Indication: Essential Hypertension
End date: 2007-03-23
Aldalix
Dosage: 50 mg, unk
Administration route: Oral
Indication: Essential Hypertension
End date: 2007-03-23
Other drugs received by patient: Spiriva; Metformin HCL; Atarax / 00058401 /
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from France on 2007-05-17
Patient:
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Cardiac Cirrhosis, Troponin Increased, Transaminases Increased, Cholelithiasis, Bronchopneumopathy, Cardiac Failure, Blood Creatinine Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 10 mg, qd
Administration route: Oral
End date: 2007-01-26
Oflocet / 00731801 /
Dosage: 400 mg, qd
Administration route: Oral
Indication: Bronchopneumopathy
Start date: 2007-01-20
End date: 2007-01-25
Aldactone
Administration route: Oral
Start date: 2007-01-21
End date: 2007-01-26
Other drugs received by patient: Augmentin / 00756801 /; Sintrom; Lasilix / 00032601 /; Diffu K; Cordarone / 00133102 /; Elisor
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from United States on 2007-03-16
Patient:
Adverse reactions / side effects: Hyperkalaemia, Nausea, Hypotension, Hyperhidrosis, Torsade DE Pointes, Malaise, Vertigo, Atrioventricular Block, Bradycardia, Blood Creatinine Increased, Blood Sodium Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 10 mg, qd
Administration route: Oral
Aldactone
Dosage: 150 mg, qd
Administration route: Oral
Indication: Cardiac Failure
Start date: 2005-05-15
End date: 2006-10-13
Other drugs received by patient: Corgard; Isoptin
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from France on 2007-03-06
Patient:
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Cardiac Cirrhosis, Troponin Increased, Transaminases Increased, Bronchopneumopathy, Cardiac Failure, Calculus Urinary, Blood Creatinine Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 10 mg, qd
Administration route: Oral
End date: 2007-01-26
Oflocet / 00731801 /
Dosage: 400 mg, qd
Administration route: Oral
Indication: Bronchopneumopathy
Start date: 2007-01-20
End date: 2007-01-25
Aldactone
Administration route: Oral
Start date: 2007-01-21
End date: 2007-01-26
Cordarone / 00133102 /
Dosage: 6 u, tablets
Administration route: Oral
Start date: 2007-01-23
End date: 2007-01-26
Augmentin / 00756801 /
Start date: 2007-01-19
Pravastatin
Dosage: 20 mg, qd
Administration route: Oral
Other drugs received by patient: Sintrom; Lasilix / 00032601 /; Diffu K
Adverse event in receiving Altace (Ramipril)
Reported by a individual with unspecified qualification from France on 2007-02-14
Patient:
Adverse reactions / side effects: Weight Decreased, Colitis Collagenous, Anaemia, International Normalised Ratio Increased, General Physical Health Deterioration, Blood Fibrinogen Increased, Activated Partial Thromboplastin Time Prolonged, Overdose, Diarrhoea, Anorexia, Oedema Peripheral, Gastroenteritis, Melaena, Blood Creatinine Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 10 mg, qd
Administration route: Oral
Start date: 2004-05-01
End date: 2006-10-04
Altace
Dosage: 10 mg, qd
Administration route: Oral
Start date: 2006-10-01
End date: 2006-10-31
Altace
Dosage: 2.5 mg, qd
Start date: 2006-11-21
Previscan / 00789001 /
Dosage: 15 mg, unk
Administration route: Oral
Start date: 2004-05-01
End date: 2006-10-04
Previscan / 00789001 /
Start date: 2006-10-01
Other drugs received by patient: Cordarone / 00133102 /; Lasilix / 00032601 /; Lasilix / 00032601 /; Cardensiel; Imovane; Temesta / 00273201 /
Adverse event in receiving Altace (Ramipril)
Reported by a physician from Canada on 2007-02-08
Patient:
Adverse reactions / side effects: Hyperkalaemia, Blood Creatinine Increased, Renal Failure Acute, Renal Artery Stenosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
End date: 2006-06-14
Irbesartan
Dosage: 150 mg, qd
Indication: Cardiovascular Event Prophylaxis
Start date: 2004-04-26
End date: 2004-05-01
Irbesartan
Dosage: 300 mg, qd
Start date: 2004-05-01
End date: 2006-06-14
Other drugs received by patient: Clopidogrel; Aspirin; Kayexalate; Lasix; Mucomyst / 00082801 /
Adverse event in receiving Altace (Ramipril)
Reported by a individual with unspecified qualification from Sweden on 2007-01-16
Patient:
Adverse reactions / side effects: Blood Blister, Pyrexia, Pallor, Polyneuropathy, Fatigue, Skin Discolouration, C-Reactive Protein Increased, Dizziness, Blood Creatinine Increased, Blister, White Blood Cell Count Increased, Vomiting, Blood Urea Increased, Dyspnoea, Atrial Flutter, Nausea, Renal Failure, Syncope, Sepsis, Vasculitis, Blood Pressure Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 2.5 mg, bid
Administration route: Oral
Indication: Atrial Fibrillation
End date: 2006-04-25
Altace
Dosage: 5 mg, bid
Administration route: Oral
Start date: 2006-04-26
End date: 2006-06-28
Furix
Dosage: 40 mg, qd
Start date: 2006-04-01
Dalacin
Dosage: 300 mg, bid
Start date: 2006-06-01
Other drugs received by patient: Metoprolol Succinate; Entocort; Isoptin; Behepan; Prednisolone ^pharmacia + Upjohn^; Allopurinol; Spironolakton ^aco^; Imodium
|
